Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $12.7 Million - $21.6 Million
-116,000 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $392,796 - $1.01 Million
-5,975 Reduced 4.9%
116,000 $12.1 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $2.72 Million - $4.75 Million
50,082 Added 69.66%
121,975 $8.63 Million
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $2.13 Million - $5.75 Million
71,893 New
71,893 $4.62 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.